Altered blood-brain-barrier function in Alzheimer's disease? |
| |
| Authors: | K. M. Mattila,T. Pirttilä ,K. Blennow,A. Wallin,M. Vitanen,H. Frey |
| |
| Affiliation: | Department of Clinical Medicine, University of Tampere, Finland;Department of Psychiatry and Neurochemistry, Gothenburg University, Mölndal Hospital, Sweden;Department of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, Sweden |
| |
| Abstract: | Alzheimer's disease (AD) and vascular dementia (VD) are the two most common causes of dementia. As yet, no definitive biological antemortem marker has been established for differential diagnosis of AD or VD. In this study, proteins of cerebrospinal fluid (CSF) from AD, VD and control patients were analyzed by two-dimensional (2-D) electrophoresis with immobilized pH gradients in the first dimension. No specific changes for AD or VD could be detected in the 2-D CSF patterns. However, a spot of haptoglobin alpha-1 chains (13.5 kDa; approximate pI 4.6) was found to be present in the majority of 2-D CSF maps from the dementia cases, suggesting a high-molecular-weight transudate type of alteration in the blood-brain barrier with considerable frequency in AD. |
| |
| Keywords: | Alzheimer's disease vascular dementia cerebrospinal fluid two-dimensional electrophoresis immobilized pH gradient blood-brain barrier haptoglobin |
|
|
